SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-202887
Filing Date
2023-08-03
Accepted
2023-08-03 16:20:09
Documents
14
Period of Report
2023-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d524173d8k.htm   iXBRL 8-K 25154
2 EX-99.1 d524173dex991.htm EX-99.1 13539
6 GRAPHIC g524173g0801232536917.jpg GRAPHIC 3395
  Complete submission text file 0001193125-23-202887.txt   167431

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20230801.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20230801_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20230801_pre.xml EX-101.PRE 10816
8 EXTRACTED XBRL INSTANCE DOCUMENT d524173d8k_htm.xml XML 3221
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 231140368
SIC: 2834 Pharmaceutical Preparations